Table
3. Chemotherapy
regimens and number of patients treated in the study
Regimen |
Number of patients
(n = 245) |
Percentage |
CHOP |
82 |
33.5 |
Hyper-CVAD |
36 |
14.7 |
ABVD-P |
35 |
14.3 |
CVAD |
19 |
7.8 |
MP |
14 |
5.7 |
GLIVEC |
10 |
4.1 |
CODOX/IVAC |
7 |
2.9 |
CAB |
4 |
1.6 |
CALGB 8811 regimen |
3 |
1.2 |
7 + 3 regimen |
2 |
0.8 |
Others |
33 |
13.5 |
TOTAL |
245 |
100 |
KEY: CHOP = Cyclophosphamide, Doxorubicin, Vincristine,
Prednisone;
CVAD= Cyclophosphamide,
Vincristine, Adriamycin, Dexamethasone;
Hyper-CVAD= Cycle A (Cyclophosphamide,
Vincristine, Adriamycin, Dexamethasone) plus Cycle B (Methotrexate,
Leucovorin, Cytarabine);
ABVD-P= Adriamycin,
Bleomycin, Vincristine, Dacarbazine, Prednisone;
CODOX/IVAC= Cyclophosphamide,
Vincristine, Doxorubicin, Methotrexate,
Ifosfamide, Etoposide, Cytarabine;
MP= Melphalan and
Prednisone; 7 + 3 regimen = Cytarabine and Daunorubicin;
CAB = Chlorambucil, CALGB 8811= Cyclophosphamide,
Daunorubicin, Vincristine
and Prednisone plus Methotrexate and Cytarabine